Sign in
Taking people in United StatesNo phase

Imaging painful inflammation in knee cap joint osteoarthritis with FDG PET/MRI scans

Tests a scan method to find painful inflammation in knee osteoarthritis.

Key facts

Who runs it
University of California, San Francisco
Where
San Francisco, United StatesSee the site
Trial code
Registry title
FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis
Status
Recruiting
People taking part
50 people, planned
Started
19 Feb 2025
Expected to end
Feb 2028
Type of study
Observational, 2 groups
Record updated
4 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with painful osteoarthritis behind the kneecap (patellofemoral joint), and healthy volunteers without knee pain for comparison. It seems to enroll people from an earlier parent study (IRB #21-34763).

Age
18 Years and older.
Sex
All sexes can join.
Disease stage
Patients: WORMS score 2-6 on knee imaging and VAS pain above 1 during 25 single-leg squats. Healthy volunteers: WORMS 0-1 and VAS pain 0-1 during 25 single-leg squats.
Earlier treatment
No steroid injections. No investigational drugs, knee injuries or knee surgeries since the last visit of the parent study.

Main reasons for not taking part

  • Pregnant or diabetic
  • Unable to do 25 single-leg squats with the study leg
  • Taking steroid injections or investigational drugs
  • New reasons you cannot have MRI or the PET tracer
  • Unable to give consent yourself

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Adult with the capacity to give informed consent
  • Ability to perform 25 single-leg squats
  • No traumatic knee injuries/surgeries since last visit for the parent study (IRB #21-34763)
  • No investigational drugs since last visit for the parent study (IRB #21-34763)
  • No contraindications to MRI or PET tracer since last visit for the parent study (IRB #21-34763)
  • Not taking steroid injections
  • Not pregnant
  • Additional inclusion criteria for healthy volunteers: Minimal pain (VAS=0-1) during a series of 25 single-leg squats on one or both legs

Who cannot take part

  • Taking investigational drugs since last visit for the parent study (IRB #21-34763)
  • Taking steroid injections
  • Inability to consent for themselves
  • Inability to perform 25 single-leg squats with the study leg
  • New traumatic knee injuries/surgeries since last visit for the parent study (IRB #21-34763)
  • New contraindications to MRI or PET tracer since last visit for the parent study (IRB #21-34763)
  • Pregnant
  • Diabetic
  • Additional exclusion criteria for healthy volunteers: VAS of 2 or greater during a series of 25 single-leg squats on both legs

Where in United States

  • UCSF Radiology China BasinSan Francisco, United StatesContact: Eric HammondTaking people

About the trial

What the trial wants to find out

This project aims to develop an [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET) / magnetic resonance imaging (MRI) method to locate the painful inflammation in PFJ OA associated with joint loading. [18F] FDG PET/MRI is an emerging pain imaging approach with enhanced sensitivity to painful hypermetabolic inflammation through evaluation of intracellular glucose utilization rate via ([18F]FDG PET) and fine anatomy details (MRI). The investigative group has shown its promise in revealing previously unidentified or unspecified pain generators in various musculoskeletal pain conditions. The investigators have also demonstrated the feasibility of visualizing the structural changes between unloaded and loaded knee joints with MRI, which can be easily adopted in the current PET/MRI setting. The main challenge in the proposed [18F]FDG PET/MRI approach is to differentiate the normal uptake of FDG for metabolic changes by weight-bearing from abnormal changes indicating eventual pain aggravation by weight-bearing and knee-flexion. The investigators have garnered the following two aims to validate the proposed method by comparing unloaded and loaded knee imaging results between PFJ OA pain patients and asymptomatic, matched controls.

The 2 groups in the trial

  • PFJ OA Patients

    Group defined as WORMS 2-6, and \>1 VAS pain during 25 single-leg squats

  • Healthy Controls

    Healthy volunteers with WORMS 0-1, and 0-1 VAS pain during 25 single-leg squats

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Understanding Painful Inflammation in Patellofemoral Joint OA Using [18F] FDG
Plain-language title
Imaging painful inflammation in knee cap joint osteoarthritis with FDG PET/MRI scansGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
4 June 2026